(2000). Agardh E: Screening and prevention of diabetic blindness. Acta Ophthalmol Scand
(2005). Boyko EJ: Diabetes-related comorbidities in Asian Americans: results of a national health survey.
(2006). Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients. Acta Diabetol
(1995). DG: Lower extremity foot ulcers and amputations in diabetes[A].
(1998). Diabetes complications and risk factors in an Australian population. How well are they managed?
(1995). Disability in Diabetes[A]. National Diabetes Data Group. Diabetes in America[M]. Bethesda 2nd edition.
(2008). Economic costs of diabetes in the U.S.
(2008). Fagot-Campagna A: Prevalence of macrovascular complications and cardiovascular risk factors in people treated for diabetes and living in France: the ENTRED study 2001. Diabetes Metab
(2003). Federation: Diabetes Atlas. 2nd edition.
(2001). Follow-up of the WHO Multinational Study of Vascular Disease in Diabetes: general description and morbidity. Diabetologia
(2005). H: The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care
(2000). Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ
(1995). Holman RR: Lessons from UK prospective diabetes study. Diabetes Res Clin Pract
(2009). How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China? Value Health
(2007). MD: Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy.
National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China.
(2004). Patients with type 2 diabetes aged 35-64 years at four primary health care centres in Stockholm County, Sweden. Prevalence and complications in relation to gender and socioeconomic status. Diabetes Res Clin Pract
(2000). Peters JR: The prevalence of multiple diabetes-related complications. Diabet Med
(1995). PJ: Mortality in Non-Insulin-Dependent Diabetes[A]. National Diabetes Data Group. Diabetes in America. Bethesda 2nd edition.
(2007). Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older. Diabetes Res Clin Pract
(1985). Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres. The World Health Organisation Multinational Study of Vascular Disease in Diabetics. Diabetes Drafting Group. Diabetologia
(1997). Prevalence of vascular complications in newly diagnosed type 2 diabetic patients.
(2007). Prevention and Control Cooperative Group: Chinese guidelines for type 2 diabetes. Beijing: Beijing Science and Technology Press;
(2002). RL: Epidemiological survey of chronic vascular complications of type 2 diabetic in-patients in four municipalities. Acta Academiae Medicinae Sinicae
(2007). Rustoen T: A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res
(1996). S: Prevalence of microalbuminuria in newly diagnosed non-insulin dependent diabetic subjects and its related factors.
(2010). Sonbo Kristiansen I: Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and Quality of Life Outcomes
(2002). The Asian-Pacific Type 2 Diabetes Policy Group: Type 2 Diabetes Practical Targets and Treatments. 3rd edition. Sydney:
(2003). The financing burden of treatment of diabetesII and Its symptom in urban China. Chinese Health Economics
(2008). The impact of complication on quality of life among diabetic patients in urban China.
(2004). The morbidity of chronic diabetic complication with logistic analysis of related potential factor.
(2003). The North-South Differences in China. Teaching Reference of Middle School Geography
(2000). The prevalence and clinical risk factors of microangopathy in type 2 diabetes mellitus.
The prevalence of diabetes has reached epidemic proportions IDF, Diabetes Atlas 4th edition. [http://www.worlddiabetesfoundation.org/ composite-35.htm]. Last updated 2-5-2010 by bisl.wdf. Accessed
(2008). TK: Prevalence and Risk Factors for Neuropathy in a Canadian First Nation Community. Diabetes Care
(2008). Tung TH: Prevalence and associated factors of lens opacities among Chinese type 2 diabetics in Kinmen, Taiwan. Acta Diabetologica
(2005). Vinik A: Metabolic memory in diabetes--focus on insulin. Diabetes Metab Res Rev
(2007). W: Survey on prevalence of complication in type 2 diabetic outpatients and its related factors. Shandong Med J
(1998). WH: Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care
(1998). Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med
(2010). Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract